CORC

浏览/检索结果: 共36条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Macroscale Superlubricity Enabled by Graphene-Coated Surfaces 期刊论文
ADVANCED SCIENCE, 2020, 卷号: 7, 期号: 4
作者:  Zhang, Zhenyu;  Du, Yuefeng;  Huang, Siling;  Meng, Fanning;  Chen, Leilei
收藏  |  浏览/下载:26/0  |  提交时间:2020/12/16
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载:56/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:44/0  |  提交时间:2019/12/05
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China 期刊论文
BMC GASTROENTEROLOGY, 2019, 卷号: 19
作者:  Sun, Jian
收藏  |  浏览/下载:41/0  |  提交时间:2019/12/05
Design of integrated impeller processing fixture and force analysis of key parts 会议论文
2019 2nd International Conference on Advanced Electronic Materials, Computers and Materials Engineering, AEMCME 2019, Changsha, China, 2019-04-19
作者:  Liao, Longxing;  Gao, Peili;  Meng, Xiangdong;  Meng, Zhaohang;  Xie, Wenxiang
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05
Subacute/chronic type A aortic dissection: a retrospective cohort study 期刊论文
2019
作者:  Wu Jinlin;  Xie Enzehua;  Qiu Juntao;  Huang Yan;  Jiang Wenxiang
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace